Oxidative Medicine and Cellular Longevity / 2015 / Article / Tab 4

Research Article

Body Composition, Lipid Profile, Adipokine Concentration, and Antioxidant Capacity Changes during Interventions to Treat Overweight with Exercise Programme and Whole-Body Cryostimulation

Table 4

Biochemical indices changes following the exercise programme.

Parameters
Min–maxMin–maxMin–maxMin–maxMin–max

Glucose mg/dL73.34 ± 17.2240.43–102.8473.28 ± 17.8036.88–111.3572.57 ± 15.3741.13–114.8979.98 ± 26.0943.97–174.8279.11 ± 12.3460.28–103.19

Uric acid mg/dL2.25 ± 0.650.98–3.411.99 ± 0.561.10–3.292.17 ± 0.731.28–3.482.47 ± 0.641.52–4.572.11 ± 0.740.95–3.9

Cholesterol mg/dL205.91 ± 37.64143–287207.32 ± 45.39140–266208.28 ± 38.29151–279189.60 ± 48.99 
122–253226.73 ± 48.41 
110–302

HDL mg/dL29.88 ± 5.2721.24–41.5928.57 ± 7.0619.47–42.0330.18 ± 6.719.47–42.5731.97 ± 4.4921.68–43.8126.97 ± 4.4921.68–43.81

LDL mg/dL146.31 ± 32.7690.2–238.8130.23 ± 25.29 
66.19–166.68131.84 ± 31.74 
93.84–233.38132.37 ± 34.22 
72.08–253.42153.10 ± 31.4153.52–197.53

TG mg/dL125.91 ± 56.7137.68–297.1108.58 ± 45.44 
57.97–220.29111.59 ± 77.45 
34.78–314.49112.45 ± 72.72 
57.97–437.68130.21 ± 57.9566.67–297.1

Adiponectin ng/mL63.64 ± 30.42 16.37–124.162.86 ± 31.7915.9–104.956.74 ± 27.9914.97–113.763.88 ± 30.8816.820–126.463.93 ± 31.3720.3–139

Resistin ng/mL4.25 ± 1.77 2.25–8.383.83 ± 1.462.01–8.384.24 ± 1.632.39–7.783.93 ± 1.541.96–7.983.80 ± 1.382.07–7.08

Leptin pg/mL239.03 ± 116.6745.68–508.2168.05 ± 89.6442.55–385.5172.86 ± 115.0924.95–559.9189.13 ± 103.240.39–520.9174.54 ± 100.5650.39–411.2

Visfatin ng/mL0.77 ± 0.50.03–2.181.05 ± 0.580.21–2.351.38 ± 0.230.19–2.091.47 ± 0.6 
0.56–2.731.37 ± 0.55 
0.50–5.74

Significance of differences at ≤ 0.05 versus before.
Significance of differences at ≤ 0.01 versus before.
Significance of differences at ≤ 0.001 versus before.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.